轻型卒中血管内治疗的实践模式与结局
基于佛罗里达-波多黎各卒中登记2010至2018年数据,4110例接受血管内治疗的缺血性卒中患者中11%为轻型(NIHSS≤5)。轻型患者到院更晚、静脉阿替普酶使用更少、穿刺时间更长,但出院回家/康复比例76%、独立行走64%,症状性颅内出血4%。
要点
- 临床实践中11%的血管内治疗患者为轻型卒中(NIHSS≤5)。
- 轻型患者到院更晚、静脉溶栓更少、门到穿刺时间更长。
- 轻型患者出院结局良好,症状性颅内出血发生率4%。
核心结论
- 尽管缺乏循证推荐,临床实践中11%的血管内治疗患者为轻型神经功能缺损。
- 数据提示轻型卒中患者接受血管内治疗安全且总体结局良好。
研究设计与样本
- 回顾性队列研究,纳入佛罗里达-波多黎各卒中登记2010年1月至2018年1月共127794例缺血性卒中患者。
- 分析其中4110例症状出现24小时内接受血管内治疗的患者,按NIHSS≤5分为轻型、NIHSS>5分为中重度。
主要发现
- 4110例血管内治疗患者中446例(11%)NIHSS≤5,中位年龄73岁,女性50%。
- 轻型患者到院中位时间138分钟 vs 中重度101分钟,静脉阿替洛酶使用30% vs 43%,门到穿刺中位时间167分钟 vs 115分钟。
- 轻型患者出院回家/康复76%、独立行走64%,中重度分别为53%和32%。
- 症状性颅内出血轻型4%、中重度6.4%。
- 多因素分析中年轻、私人保险、高血压史、既往独立行走和医院规模与NIHSS≤5独立相关。
临床怎么用
- 临床实践中可考虑对符合条件的轻型卒中患者实施血管内治疗,但需注意其到院延迟和溶栓率较低的特点。
- 应关注轻型患者血管内治疗后的症状性颅内出血风险(4%)。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We aimed to evaluate the current practice patterns, safety and outcomes of patients who receive endovascular therapy (EVT) having mild neurological symptoms. Methods- From Jan 2010 to Jan 2018, 127,794 ischemic stroke patients were enrolled in the Florida-Puerto Rico Stroke Registry. Patients presenting within 24 hours of symptoms who received EVT were classified into mild (National Institutes of Health Stroke Scale [NIHSS] ≤5) or moderate/severe (NIHSS>5) categories. Differences in clinical characteristics and outcomes were evaluated using multivariable logistic regression. Results- Among 4110 EVT patients (median age, 73 [interquartile range=20] years; 50% women), 446 (11%) had NIHSS ≤5. Compared with NIHSS >5, those with NIHSS ≤5 arrived later to the hospital (median, 138 versus 101 minutes), were less likely to receive intravenous alteplase (30% versus 43%), had a longer door-to-puncture time (median, 167 versus 115 minutes) and more likely treated in South Florida (64% versus 53%). In multivariable analysis younger age, private insurance (versus Medicare), history of hypertension, prior independent ambulation and hospital size were independent characteristics associated with NIHSS ≤5. Among EVT patients with NIHSS ≤5, 76% were discharged home/rehabilitation and 64% were able to ambulate independently at discharge as compared with 53% and 32% of patients with NIHSS >5. Symptomatic intracerebral hemorrhage occurred in 4% of mild stroke EVT patients and 6.4% in those with NIHSS >5. Conclusions- Despite lack of evidence-based recommendations, 11% of patients receiving EVT in clinical practice have mild neurological presentations. Individual, hospital and geographic disparities are observed among endovascularly treated patients based on the severity of clinical symptoms. Our data suggest safety and overall favorable outcomes for EVT patients with mild stroke.
引用
- Asdaghi N, Yavagal DR, Wang K, et al. Patterns and Outcomes of Endovascular Therapy in Mild Stroke. Stroke. 2019. PMID: 31303151. doi:10.1161/STROKEAHA.118.023893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。